The report is the latest indictment of America’s broken healthcare system.
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
Newer entrants to the pharmacy benefit management market will continue to face stiff competition in 2025 as they seek more ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs. FTC’s report ...